Uterine Diseases D014591

Description

Pathological processes involving any part of the UTERUS.   MeSH

Subtype Terms (13)

Adenomyosis
25 drugs (20 approved, 5 experimental)

Endometrial Hyperplasia
27 drugs (19 approved, 8 experimental)

Endometritis
18 approved drugs

Hematometra
 

Pyometra
 

Uterine Cervical Diseases
6 drugs (5 approved, 1 experimental)

Uterine Duplication Anomalies
 

Uterine Hemorrhage
22 drugs (18 approved, 4 experimental)

Uterine Inversion
 

Uterine Neoplasms
117 drugs (82 approved, 35 experimental)

Uterine Prolapse
12 drugs (9 approved, 3 experimental)

Uterine Retroversion
 

Uterine Rupture
1 approved drug


Phase 1 Indicated Drugs (2)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.